Pharmaceutical Compliance Monitor

pharmacompliancemonitor.com

Pharma Compliance Monitor (PCM) is only publication that spotlights regulatory and compliance news and developments for the pharmaceutical and biotechnology communities. PCM’s ongoing goal is to create a place where pharmaceutical and biotechnology professionals and executives can go to stay informed, interact and learn. Read by senior compliance professionals and executives at many of the largest research-based pharmaceutical and biotechonology manufacturers, PCM speaks to the decision maker faced with making mission critical choices that anchor best-in-class corporate compliance and ethics programs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

TEVA ANNOUNCES UNIQUE COLLABORATION WITH HEALTHSNAP TO EXPAND THE REACH OF ITS RESPIRATORY DIGITAL HEALTH PLATFORM

Teva Pharmaceuticals | November 21, 2022

news image

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a new collaboration with HealthSnap, a leading full-service Virtual Care Management Platform for chronic disease management. The collaboration will enable more consumers to have access to Teva’s Digihaler® system, a digital health platform designed to enable patients to have more informed treatment discussions with their healthcare providers through personalized care. The collaboratio...

Read More

Business Insights

MITSUBISHI TANABE PHARMA AMERICA HIGHLIGHTS LATEST RESEARCH IN PARKINSON'S DISEASE AT EAN AND WPC 2023 CONGRESSES

prnewswire | July 06, 2023

news image

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of seven abstracts in Parkinson's disease (PD) at the 9th Congress of the European Academy of Neurology (EAN), which was held in Budapest, July 1-3, and the 6th World Parkinson Congress (WPC), being held in Barcelona, July 4-7. "Our presence at EAN and WPC this year underscores MTPA's dedication to investigating potential treatment options to tackle the current unmet needs and challenges ...

Read More

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

news image

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More

Pharmacy Market

NRX PHARMACEUTICALS TO WORK WITH CARDINAL HEALTH TO ENSURE EFFICIENT DISTRIBUTION OF POTENTIAL THERAPIES

NRx Pharmaceuticals | August 26, 2021

news image

NRx Pharmaceuticals announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of ZYESAMI™ upon the potential Emergency Use Authorization (EUA) approval by the US Food and Drug Administration (FDA). In May, NRx submitted an application for EUA to the FDA for ZYESAMI™ (aviptadil) for patients suffering from Critical COVID-19 with respiratory failure. "This partnership creates an efficient and highly flexible lo...

Read More
news image

Business Insights

TEVA ANNOUNCES UNIQUE COLLABORATION WITH HEALTHSNAP TO EXPAND THE REACH OF ITS RESPIRATORY DIGITAL HEALTH PLATFORM

Teva Pharmaceuticals | November 21, 2022

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a new collaboration with HealthSnap, a leading full-service Virtual Care Management Platform for chronic disease management. The collaboration will enable more consumers to have access to Teva’s Digihaler® system, a digital health platform designed to enable patients to have more informed treatment discussions with their healthcare providers through personalized care. The collaboratio...

Read More
news image

Business Insights

MITSUBISHI TANABE PHARMA AMERICA HIGHLIGHTS LATEST RESEARCH IN PARKINSON'S DISEASE AT EAN AND WPC 2023 CONGRESSES

prnewswire | July 06, 2023

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of seven abstracts in Parkinson's disease (PD) at the 9th Congress of the European Academy of Neurology (EAN), which was held in Budapest, July 1-3, and the 6th World Parkinson Congress (WPC), being held in Barcelona, July 4-7. "Our presence at EAN and WPC this year underscores MTPA's dedication to investigating potential treatment options to tackle the current unmet needs and challenges ...

Read More
news image

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More
news image

Pharmacy Market

NRX PHARMACEUTICALS TO WORK WITH CARDINAL HEALTH TO ENSURE EFFICIENT DISTRIBUTION OF POTENTIAL THERAPIES

NRx Pharmaceuticals | August 26, 2021

NRx Pharmaceuticals announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of ZYESAMI™ upon the potential Emergency Use Authorization (EUA) approval by the US Food and Drug Administration (FDA). In May, NRx submitted an application for EUA to the FDA for ZYESAMI™ (aviptadil) for patients suffering from Critical COVID-19 with respiratory failure. "This partnership creates an efficient and highly flexible lo...

Read More